 |
Eighth Annual Award Recipient
Gabriel N. Hortobagyi, M.D.
Professor and Chair
Department of Breast Medical Oncology
UT MD Anderson Cancer Center
Houston, TX
|
Dr. Hortobagyi delivered his award lecture titled
Dual Targeting for Endocrine Therapy of Breast Cancer, at the AACR Annual Meeting 2013 in Washington, D.C. The award ceremony and lecture was held on Sunday, April 7, 2013. Visit the
AACR Annual Meeting 2013 page for more information on the Annual Meeting.
The Lectureship
The AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship was first presented in 2006. The lectureship is intended to give recognition to an outstanding scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of minority investigators in cancer research.
Learn more about Dr. Jane Cooke Wright.
Eligibility
- Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.
- The lectureship will be presented to an individual investigator.
- Institutions or organizations are not eligible for the lectureship.
Nomination Process
Nominations are closed.
Nominations may be by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves.
Selection
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the winner will be made on the basis of the candidate's contributions to the field of cancer research and to the advancement of minorities. No regard will be given to age, race, gender, nationality, geographic location or religious or political views.
Supporter
Supported by AACR-Minorities in Cancer Research.
Questions?
Linda Stokes, Program Associate
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404
awards@aacr.org
SPOTLIGHT
|
Seventh Annual Recipient
Pelayo Correa, M.D.
Anne Potter Wilson Professor of Medicine
Division of Gastroenterology, Hepatology, and Nutrition
Vanderbilt University Medical Center
Nashville, TN
|
Dr. Pelayo Correa delivered his award lecture titled, Gastric Cancer: An Infectious Disease, on Sunday, April 1, 2012, during the AACR Annual Meeting 2012 in Chicago, IL. He recieved his award from Dr. Levi Garraway, MICR Council chairperson(left) and Dr. Ana M. Gonzalez-Angulo, Selection Committee member.
________________________________________________________________________
Dr. Pelayo Correa is the first Anne Potter Wilson endowed chair in cancer research at Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. Dr. Correa’s distinguished career began in the early 1950s, and he remains quite active to this day in conducting gastric cancer research and in performing clinical trials to manage the disease in populations throughout Latin America. He has been working with epidemiologic information on patients who have been monitored and followed for at least 20 years.
Dr. Correa obtained his medical degree from the Universidad de Antioquia in Colombia, where he also did his internship, and he completed residency training in pathology at Emory University. Returning to Colombia, he ascended to professor and chair of the department of pathology as well as associate dean of biomedical research at the Universidad del Valle in Cali, Colombia. Later he became professor of pathology and the Boyd professor of pathology at the Louisiana State University Medical Center from 1996 until 2006 when Hurricane Katrina struck New Orleans and destroyed his work and laboratory. Dr. Correa is rebuilding and continuing his research program at the Vanderbilt-Ingram Cancer Center.
Dr. Correa has been a role model and inspiration for Latin American and other minority scientists and is honored for his groundbreaking research contributions to gastric cancer that has spanned more than five decades. He is internationally recognized for his definitive work in studying the mucosal changes leading to the development of gastric carcinoma utilizing histologic staging now known as “Correa’s cascade.” His research on the mechanisms of H. pylori as an infectious agent and its relationship to gastric cancer is widely recognized internationally. His research has led to various clinical trials utilizing a variety of treatment modalities to prevent and control the disease process. Gastric cancer is known to be the second-leading cause of cancer-related mortality in the world, and H. pylori bacteria is a known strong risk factor for this cancer. Dr. Correa’s work has contributed to our understanding of gastric cancer in populations throughout the world.
Although H. pylori has been associated with gastric cancer in some populations, not all patients with H. pylori have gastric cancer. Dr. Correa’s group is researching and comparing the various effects of H. pylori in the development of gastric cancer in various ethnic populations throughout the world; his group is taking into account the epidemiological studies of how environmental and genetic factors contribute to the disease’s process.
As a mentor, Dr. Correa has enhanced the scientific careers and research capabilities of his colleagues in Latin America and the United States; and decades of younger investigators have benefitted greatly from his expertise and guidance.
Dr. Correa is the recipient of many honors and distinguished awards, including the First American Cancer Society Award on Cancer Epidemiology and Prevention, Distinguished Achievement Award of the American Society of Preventive Oncology and Fellow of the American Association for the Achievement of Science; and has an impressive body of publications numbering more than 500. Dr. Correa is also the founding editor of the AACR journal Cancer, Epidemiology, Biomarkers and Prevention.